The emergence of multidrug-resistant (MDR) Gram-negative bacilli creates a challenge in
the treatment of nosocomial infections. While the pharmaceutical pipeline is waning, two …

The recent expansion of multidrug resistant and pan-drug-resistant pathogens poses
significant challenges in the treatment of healthcare associated infections. An important …

Purpose To describe the current standards of care and major recent advances with regard
to antimicrobial resistance (AMR) and to give a prospective overview for the next 30 years in …

Emerging evidence shows that severe coronavirus disease 2019 (COVID‐19) can be
complicated with coagulopathy, namely disseminated intravascular coagulation, which has a …

Background . We describe the emergence and spread of Klebsiella pneumoniae
carbapenemase 2 (KPC-2)–producing K. pneumoniae at a Greek University hospital. Methods . …

Fosfomycin is active in vitro against extensively drug-resistant (XDR) and pandrug-resistant (PDR)
Pseudomonas aeruginosa and Klebsiella pneumoniae carbapenemase-producing …

Background: It was studied if early suPAR-guided anakinra treatment can prevent severe
respiratory failure (SRF) of COVID-19. Methods: A total of 130 patients with suPAR ≥6 ng/ml …

PURPOSE: The experience with high-flow nasal cannula (HFNC) oxygen therapy in severe
acute respiratory infection (SARI) is limited. The objective was to assess the effectiveness of …

Background Coronavirus disease-19 (COVID-19) is implicated by active endotheliitis, and
cardiovascular morbidity. The long-COVID-19 syndrome implications in atherosclerosis have …

Life-threatening “breakthrough” cases of critical COVID-19 are attributed to poor or waning
antibody (Ab) response to SARS-CoV-2 vaccines in individuals already at risk. Preexisting …